One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Finerenone in Patients With a Recent Worsening Heart Failure Event: The FINEARTS-HF Trial
Worsening Heart Failure: An Opportunity for Treatment Implementation Even With a Preserved Ejection Fraction?
Effect of Finerenone on the KCCQ in Patients With HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HF
The FINE ART of Interpreting Health Status Benefits in Clinical Trials
Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: Prespecified Analysis of FINEARTS-HF
Obesity-Related Heart Failure With Preserved Ejection Fraction: Weighing the Benefit of Finerenone
Finerenone and Kidney Outcomes in Patients With Heart Failure: The FINEARTS-HF Trial
Unentangling Heart Failure From Kidney Outcomes With Finerenone: Insights From the FINEARTS-HF Trial
Initial Decline in Glomerular Filtration Rate With Finerenone in HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HF
When Kidney Function Declines But Therapy Still Works: The Case for Nonsteroidal MRA Therapy in Heart Failure
Did Finerenone Improve Health Status in the FINEARTS Trial?: A Critical Reevaluation of the Analysis of Patient-Reported Outcomes in Heart Failure
Time to Significant Benefit of Finerenone in Patients With Heart Failure
Implantable Loop Recorders in Patients With Brugada Syndrome: What Is the Appropriate Use in These Patients?
Reply: Implantable Loop Recorders in Patients With Brugada Syndrome: What Is the Appropriate Use in These Patients?
